MedTrace Logo

Telemedicine-Based Virtual Reality Clinic for the Treatment of Phobias

NCT06302868 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2026-05-18

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to assess the feasibility of conducting a randomized controlled efficacy trial comparing the delivery of exposure therapy via a telemedicine-based virtual reality clinic (Doxy.me VR) vs. standard telemental health (TMH) to adults with intense fear of dogs, snakes, and/or spiders. The secondary purpose is to preliminarily examine the efficacy of using Doxy.me VR vs. TMH in reducing phobia severity.

Conditions

  • Arachnophobia
  • Cynophobia
  • Ophidiophobia

Interventions

BEHAVIORAL

Telemedicine Exposure Therapy Using Photos and Videos

Participants will complete 12 60-minute exposure therapy sessions using photos/videos and progress to in vivo exposures.

BEHAVIORAL

Telemedicine-Based Virtual Reality Exposure Therapy

Participants will complete 12 60-minute exposure therapy sessions in a Virtual Reality Clinic using Virtual Reality stimuli and progress to in vivo exposures.

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • University of South Florida

    lead OTHER

Principal Investigators

  • Brian E Bunnell, PhD · University of South Florida

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-25
Primary Completion
2024-07-26
Completion
2024-07-26

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06302868 on ClinicalTrials.gov